What amount sold does Glenveigh Pharmaceuticals, LLC report in Form D filings?

The latest linked filings report $1.4M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Glenveigh Pharmaceuticals, LLC's most recent SEC filing?

Glenveigh Pharmaceuticals, LLC's most recent Form D filing was on 2012-05-14.

How many investors does Glenveigh Pharmaceuticals, LLC have?

The most recent Form D filing lists 1 investor(s).

What type of securities does Glenveigh Pharmaceuticals, LLC offer?

Glenveigh Pharmaceuticals, LLC's SEC Form D filings indicate equity offerings.

Glenveigh Pharmaceuticals, LLC

CIK: 0001535853·Biotechnology·CHATTANOOGA, TN·Limited Liability Company

Reported Sold

$1,350,000

Total Filings

Identified Offerings

Last Filed

May 14, 2012

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

May 14, 2012Form D — New notice

Reported sold: $1,100,000 · Target: $1,750,000

Rule 506·1 investor

Nov 29, 2011Form D — New notice

Reported sold: $250,000 · Target: $2,500,000

Rule 506·1 investor

Fundraising Profile

Exemptions

Rule 506

Investors in latest filing

Revenue Range

$1 - $1,000,000

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 2 identified offerings

$1,350,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Charles David Adair

Related Person

Appears on 2 filings

Richard C Proctor, Jr.

Related Person

Appears on 2 filings

Mark David Hackett

Related Person

Appears on 2 filings

Lizbeth Kennedy-Thomas

Related Person

Appears on 2 filings

Ken Couch

Related Person

Appears on 2 filings

William R Russell

Related Person

Appears on 2 filings

Richard Becherer

Related Person

Appears on 2 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
May 14, 2012	New	$1,750,000	$1,100,000	1
Nov 29, 2011	New	$2,500,000	$250,000	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Accufy Diagnostics, Inc.

Biotechnology

Offering target: $2,000,000

Filed Oct 28, 2026